Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)

Clinical trial NCT01433731 · COMPLETED

Trial details

NCT number: NCT01433731
Sponsor: TetraLogic Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Cutaneous

Start date: 2011-11-01
Primary completion: 2013-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.